RESMED INC — Director's Dealing 2020

Aug 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-08-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-03	ResMed Common Stock	M	5919	$57.76	Acquired	139081	Direct
2020-08-03	ResMed Common Stock	S	5919	$201.9924	Disposed	133162	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-03	ResMed Common Stock Options	$57.76	M	5919	Disposed	2023-11-16	ResMed Common Stock (5919)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Balance adjusted by duplicate reporting of 780 performance units earned on June 4, 2020 originally reported as banked shares on April 19, 2018.

F3: This transaction was executed in multiple trades at prices ranging from $200.61 to $202.98. The price reported above reflects the weighted average sale price.

F4: Represents date options first became exercisable. Options vest 1/3 per year.